Andere Sprachen Photocure ASA

Aktien

931150

NO0010000045

PHO

Markt geschlossen - Oslo Bors Andere Börsenplätze 16:45:00 28.06.2024			% 5 Tage	% 1. Jan.
59,1 ^NOK	-1,99 %		-3,90 %	-12,31 %

04.06.	Photocure ASA kündigt mobile BLC-Tower-Initiative zur Erweiterung des Zugangs zu Cysview in den USA an	CI
23.05.	Photocure ASA gibt die Ernennung von Vorstandsmitgliedern bekannt	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Photocure ASA Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S	04.06.
Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.	04.06.
Photocure ASA Announces Board Appointments	23.05.
Photocure ASA - Annual general meeting held	23.05.
Photocure ASA, Results for the first quarter of 2024	16.05.
Photocure ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Photocure ASA Reiterates Financial Guidance for the Year 2024	15.05.
Photocure ASA: Results for the first quarter of 2024	15.05.
Photocure Partner Wins Acceptance for Chinese Regulatory Review Application	13.05.
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China	12.05.
Photocure ASA: Invitation to presentation of first quarter 2024 financial results	08.05.
Photocure ASA Announces Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology	07.05.
Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024	07.05.
Photocure ASA - Notice of the Annual General Meeting 23 May 2024	30.04.
Photocure ASA: Annual Report 2023	30.04.
Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy	30.04.
Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy	30.04.
Photocure ASA Announces Pivotal Trial Results and New Real-World Evidence	30.04.
Photocure ASA - Share option grant	25.04.
Photocure ASA - European Association of Urology 2024 congress features new data on modern technology use in bladder cancer care	09.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Photocure ASA

Aktien

931150

NO0010000045

PHO

Andere Sprachen

Filter